FDA Expands AYON System Clearance, Adding Power Liposuction for Apyx Medical
Summary
Apyx Medical Corporation has secured expanded FDA 510(k) clearance for its AYON Body Contouring System, now including power liposuction capability. This significant regulatory approval integrates an advanced liposuction modality, utilizing a reciprocating cannula to enhance fat removal efficiency, thereby reducing surgeon effort and operating room time. The company anticipates this addition will drive greater market demand for AYON, positioning it as a more comprehensive solution in surgical aesthetics. This development is a material positive for Apyx Medical, expanding the product's competitive features and potential revenue streams. A limited commercial launch of the new function is planned to optimize adoption.
At the time of this announcement, APYX was trading at $3.78 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $153.7M. The 52-week trading range was $1.08 to $4.50. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.